Open AccessRetrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer
Author(s) -
Ali Murat Tatlı,
Deniz Arslan,
Mükremın Uysal,
Sema Sezgin Göksu,
Şeyda Gündüz,
Hasan Şenol Çoşkun,
Mustafa Özdoğan,
Burhan Savaş,
Hakan Bozcuk
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.146092
Subject(s) - oncology , chemotherapy , lung cancer , medicine , retrospective cohort study
First- and second-line chemotherapies have been demonstrated to be effective in treatment of patients with inoperable, advanced non-small cell lung cancer (NSCLC), although the role of third-line chemotherapy remains unclear. The present investigation assessed treatment outcomes in patients with advanced NSCLC who received third-line and higher chemotherapy.